"World-class clinical trial expertise and state of the art facilities. We conduct a wide range of clinical trials, with a focus on early stage clinical research. We have an on-site laboratory and pharmacy and are located in the new Bright Alliance Building, in the major research precinct with Prince of Wales Hospital, Royal Hospital for Women, UNSW Sydney and the Lowy Cancer Research Centre. Contact us at 1800 727 874."

During the past decade, Scientia Clinical Research conducted 54 clinical trials. In the 10-year time frame, 54 clinical trials started and 3 clinical trials were completed, i.e. on average, 5.6% percent of trials that started reached the finish line to date. In the past 5 years, 35 clinical trials started and 3 clinical trials were completed. i.e. 8.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Scientia Clinical Research" #1 sponsor was "Atridia Pty Ltd." with 3 trials, followed by "Blade Therapeutics" with 3 trials sponsored, "CStone Pharmaceuticals" with 3 trials sponsored, "Janssen Research & Development, LLC" with 3 trials sponsored and "Agenus Inc." with 3 trials sponsored. Other sponsors include 35 different institutions and companies that sponsored additional 40 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Scientia Clinical Research" #1 collaborator was "Clinical Network Services (CNS) Pty Ltd" with 2 trials as a collaborator, "Novotech (Australia) Pty Limited" with 2 trials as a collaborator, "ATOGEN AUSTRALIA PTY LTD" with 1 trials as a collaborator, "Bionet Co., Ltd" with 1 trials as a collaborator and "Bristol-Myers Squibb" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Scientia Clinical Research" are "Advanced Solid Tumor" (7 trials), "Healthy Volunteers" (6 trials), "Advanced Solid Tumors" (4 trials), "Atopic Dermatitis" (3 trials) and "Bladder Cancer" (3 trials). Many other conditions were trialed in "Scientia Clinical Research" in a lesser frequency.

Most popular intervention types in "Scientia Clinical Research" are "Drug" (45 trials), "Biological" (13 trials) and "Other" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "BLD-0409" (2 trials), "JNJ-67856633" (2 trials), "Nivolumab" (2 trials) and "ABN401- Escalation Phase" (1 trials). Other intervention names were less common.

The vast majority of trials in "Scientia Clinical Research" are 50 trials for "All" genders, 2 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Scientia Clinical Research". 2 are not yet recruiting, 15 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 26 completed trials in Scientia Clinical Research, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Scientia Clinical Research, 51 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".